Eyenovia Inc
NASDAQ:EYEN 4:00:00 PM EDT
| Market Cap (Intraday) | 36.00M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.63 |
| 50-Day MA | $1.24 |
| 200-Day MA | $1.60 |
Eyenovia Inc Stock, NASDAQ:EYEN
295 Madison Avenue, Suite 2400, New York, New York 10017
United States of America
Phone: +1.833.393.6684
Number of Employees: 57
Description
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.